Indian Supreme Court Dismisses Novartis’ Patent Claim for Its Cancer Drug

by Kathy Jones on  April 1, 2013 at 6:05 PM Medico Legal News
RSS Email Print This Page Comment
Swiss pharmaceutical giants Novartis has received a huge blow to its Indian operations after the country's Supreme Court dismissed a patent request for its cancer drug, Glivec.
 Indian Supreme Court Dismisses Novartis’ Patent Claim for Its Cancer Drug
Indian Supreme Court Dismisses Novartis’ Patent Claim for Its Cancer Drug
Advertisement

The Supreme Court ruled that the compound for which Novartis was seeking a patent "did not satisfy the test of novelty or inventiveness" required by Indian law.

Advertisement
Source: AFP
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Cancer and Homeopathy Signature Drug Toxicity Cancer Facts Cancer Tattoos A Body Art Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant 
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive